---
title: "Encompass Design India Ltd (ENCOMPAS) — Share Price, Financials & Analysis"
symbol: "ENCOMPAS"
company: "Encompass Design India Ltd"
canonical: "https://tapetide.com/stocks/ENCOMPAS"
isin: "INE433T01015"
nse_symbol: "ENCOMPAS"
sector: "Commercial Services"
industry: "Trading & Distributors"
market_cap_cr: 370.19
generated_at: "2026-09-13T18:57:15.306Z"
---

# Encompass Design India Ltd (ENCOMPAS)

Canonical page: https://tapetide.com/stocks/ENCOMPAS

## Company

- **NSE Symbol:** ENCOMPAS
- **ISIN:** INE433T01015
- **Sector:** Commercial Services
- **Industry:** Trading & Distributors
- **Macro Sector:** Services
- **Stock Type:** EQUITY
- **Listed Since:** 2025-12-12
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** edipl.in

## About

Incorporated in March 2010, Encompass Design India Limited (EDIL), known as ‘' ScaleSauce',’ builds and scales consumer brands in India.[1]

## Latest Price

- **Price:** ₹259.5
- **Change:** +0.5 (+0.19%)
- **Open:** ₹261
- **Day High:** ₹261
- **Day Low:** ₹259.5
- **Previous Close:** ₹259
- **Volume:** 800
- **As Of:** 2026-09-11T06:00:12+00:00

## Key Fundamentals

Observed at 2026-09-11T04:48:46.021989Z.

- **Market Cap:** ₹370.19 Cr
- **Classification:** SME
- **P/E (reported):** 0
- **Book Value:** ₹51.32
- **Price to Book:** 5.05
- **Dividend Yield:** 0%
- **ROE:** 33.13%
- **ROCE:** 40.49%
- **Debt to Equity:** 0.16
- **Revenue (yearly):** ₹68.12 Cr
- **Net Income:** ₹12.81 Cr
- **EBITDA:** ₹20.76 Cr
- **52-Week High:** ₹302.9
- **52-Week Low:** ₹167.35
- **RSI (14):** 59.84

## Key Insights

### Strengths

- Company has a good return on equity (ROE) track record: 3 Years ROE 35.9%

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 60.8 days to 93.4 days

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | -27.08% | 51.92% | -65.75% |
| ebitda margin growth | -3.03% | 7.7% | — |
| net income growth | 18.61% | 130% | — |
| revenue growth | 23.85% | 47% | — |
| roce | -26.86% | -578.04% | — |
| roe | -50.03% | 20.8% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Sales | 39 | 28 | 40 |
| Expenses | 25 | 19 | 28 |
| Operating Profit | 14 | 9 | 12 |
| OPM % | 35 | 31 | 30 |
| Other Income | 0 | 0 | 0 |
| Interest | 0 | 0 | 1 |
| Depreciation | 1 | 2 | 1 |
| Profit before tax | 13 | 7 | 10 |
| Tax % | 25 | 25 | 17 |
| Net Profit | 10 | 5 | 8 |
| EPS in Rs | 244.03 | 4.84 | 5.62 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Sales | 22 | 40 | 55 | 68 |
| Expenses | 21 | 29 | 38 | 47 |
| Operating Profit | 1 | 11 | 17 | 21 |
| OPM % | 2.6 | 28 | 31 | 30 |
| Other Income | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 2 |
| Depreciation | 2 | 2 | 2 | 3 |
| Profit before tax | -1 | 9 | 15 | 16 |
| Tax % | 33 | 26 | 26 | 20 |
| Net Profit | -1 | 7 | 11 | 13 |
| EPS in Rs | -49.12 | 232.35 | 276.88 | 9.18 |
| Dividend Payout % | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Equity Capital | 0.26 | 0.3 | 0.39 | 14 |
| Reserves | 3 | 10 | 32 | 68 |
| Borrowings | 8 | 8 | 14 | 13 |
| Other Liabilities | 13 | 5 | 7 | 8 |
| Total Liabilities | 24 | 23 | 53 | 102 |
| Fixed Assets | 6 | 11 | 19 | 45 |
| CWIP | 0 | 0 | 0 | 7 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 18 | 12 | 35 | 50 |
| Total Assets | 24 | 23 | 53 | 102 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Cash from Operating Activity | 3 | 6 | 5 | 6 |
| Cash from Investing Activity | -1 | -7 | -10 | -37 |
| Cash from Financing Activity | -3 | 0 | 17 | 33 |
| Net Cash Flow | 0 | 0 | 12 | 3 |
| Free Cash Flow | 3 | 0 | -5 | -31 |
| CFO/OP | 557 | 63 | 37 | 31 |

### Ratios

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Debtor Days | 40 | 43 | 60 | 65 |
| Inventory Days | 389 | 105 | 157 | 187 |
| Days Payable | 205 | 29 | 13 | 8 |
| Cash Conversion Cycle | 223 | 119 | 204 | 244 |
| Working Capital Days | 57 | 52 | 37 | 93 |
| ROCE % | — | 66 | 46 | 26 |

## Shareholding Pattern

### Quarterly

| Category | Dec 2025 | Mar 2026 |
| --- | --- | --- |
| Promoters | 58.94% | 58.94% |
| FIIs | 7.87% | 7.12% |
| DIIs | 4.7% | 1.9% |
| Government | 0% | 0% |
| Public | 23.63% | 22.35% |
| Others | 4.86% | 9.69% |
| No. of Shareholders | 700 | 278 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 7 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 255.29 | Buy |
| EMA (10) | 255.66 | Buy |
| SMA (20) | 249.11 | Buy |
| EMA (20) | 251.59 | Buy |
| SMA (50) | 245.14 | Buy |
| EMA (50) | 246.76 | Buy |
| SMA (100) | 242.76 | Buy |
| EMA (100) | 243.8 | Buy |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 60.23 | Neutral |
| MACD (12,26,9) | 4.61 | Buy |
| Stochastic (14,3,3) | 87.08 | Sell |
| ADX (14) | 10.62 | Neutral |
| Williams %R (14) | -15.25 | Sell |
| ATR (14) | 7.36 | Neutral |
| ROC (12) | 6.79 | Buy |
| Stoch RSI (14) | 75.22 | Neutral |
| UO (7,14,28) | 68.05 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Sep - Newspaper publication for 16th AGM notice and e-voting on September 30, 2026. | [Copy of Newspaper Publication 9 Sep - Newspaper publication for 16th AGM notice and e-voting on September 30, 2026.](https://nsearchives.nseindia.com/corporate/EDILIPO_09092026133959_Intimation_of_Newspaper_Publication.pdf) |
| 9 July 2026 - Encompass Design incorporated The Longevity Plan Private Limited as subsidiary on July 8, 2026. | [General Updates 9 July 2026 - Encompass Design incorporated The Longevity Plan Private Limited as subsidiary on July 8, 2026.](https://nsearchives.nseindia.com/corporate/EDILIPO_09072026195410_Intimation_under_Reg_30_Incorporation_of_Subsidiary.pdf) |
| 8 Sep - 16th AGM on 30 September 2026 via VC/OAVM; adopted FY26 accounts and reappoints Susmita Amit Dalmia. | [Shareholders meeting 8 Sep - 16th AGM on 30 September 2026 via VC/OAVM; adopted FY26 accounts and reappoints Susmita Amit Dalmia.](https://nsearchives.nseindia.com/corporate/EDILIPO_08092026232004_Notice_of_AGM-Encompass.pdf) |
| 7 March 2026 - EGM on March 30, 2026 at 4:00 PM via VC; newspaper notice and e-voting published. | [Copy of Newspaper Publication 7 March 2026 - EGM on March 30, 2026 at 4:00 PM via VC; newspaper notice and e-voting published.](https://nsearchives.nseindia.com/corporate/EDILIPO_07032026135826_Intimation_of_Newspaper_publication-EDIL.pdf) |
| 6 March 2026 - EGM on 30 March 2026 to reallocate ₹115.57 lakh unutilised IPO proceeds to working capital. | [Shareholders meeting 6 March 2026 - EGM on 30 March 2026 to reallocate ₹115.57 lakh unutilised IPO proceeds to working capital.](https://nsearchives.nseindia.com/corporate/EDILIPO_06032026200144_Notice_of_EGM_Encompass_Design_India_Limited.pdf) |
| 6 March 2026 - Approved reallocation of 2.87% IPO proceeds to working capital; EGM set, scrutinizer appointed; proposed Indian subsidiary. | [Outcome of Board Meeting 6 March 2026 - Approved reallocation of 2.87% IPO proceeds to working capital; EGM set, scrutinizer appointed; proposed Indian subsidiary.](https://nsearchives.nseindia.com/corporate/EDILIPO_06032026201048_Revised_Outcome_of_BM.pdf) |
| 6 March 2026 - 06/03/2026: Board proposes reallocating 2.87% IPO proceeds to working capital; calls EGM; to incorporate Indian subsidiary. | [Incorporation 6 March 2026 - 06/03/2026: Board proposes reallocating 2.87% IPO proceeds to working capital; calls EGM; to incorporate Indian subsidiary.](https://nsearchives.nseindia.com/corporate/EDILIPO_06032026201627_Disclosure_under_Regulations_30.pdf) |
| 6 March 2026 - 06/03/2026: Board approved varying IPO objects reallocating 2.87% proceeds; EGM set; proposed pharmaceutical subsidiary | [Outcome of Board Meeting 6 March 2026 - 06/03/2026: Board approved varying IPO objects reallocating 2.87% proceeds; EGM set; proposed pharmaceutical subsidiary](https://nsearchives.nseindia.com/corporate/EDILIPO_06032026182424_Outcome_of_BM.pdf) |
| 31 March 2026 - EGM on 30 Mar 2026 approved special resolution varying prospectus objects; 8,100,765 votes (57.11% outstanding) all in favor. | [Shareholders meeting 31 March 2026 - EGM on 30 Mar 2026 approved special resolution varying prospectus objects; 8,100,765 votes (57.11% outstanding) all in favor.](https://nsearchives.nseindia.com/corporate/EDILIPO_31032026172016_Scrutinizer_Report_along_with_Voting_Results.pdf) |
| 30 March 2026 - March 30, 2026 EGM to vary company prospectus objects; remote e-voting Mar 27–29. | [Shareholders meeting 30 March 2026 - March 30, 2026 EGM to vary company prospectus objects; remote e-voting Mar 27–29.](https://nsearchives.nseindia.com/corporate/EDILIPO_30032026194405_Proceeding_of_EGM.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_31993_ENCOMPAS_2025_2026_A_210958_08092026233111.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:57:15.306Z.